If you or a loved one were diagnosed with a meningioma brain tumor or spinal cord tumor after taking Depo-Provera or Depo-SubQ Provera injections, you may be entitled to recover compensation from a Depo-Provera lawsuit case or settlement claim.
A team of drug injury lawyers and class action attorneys is investigating potential Depo-Provera lawsuit and settlement cases of women who suffered from a meningioma brain tumor and/or spinal cord tumor after using Depo-Provera or Depo-SubQ Provera.
Depo-Provera and Depo-SubQ Provera (medroxyprogesterone acetate) are progestin hormone birth control shots or contraceptive medication injections used to prevent pregnancy (and/or treat endometriosis) by suppressing ovulation (preventing the ovaries from releasing eggs) and by thickening the cervical mucus to prevent sperm from getting to an egg. Depo-Provera is typically given via a 150 mg intramuscular injection in the gluteal (buttocks) or deltoid (upper arm) muscle every three months.
Unfortunately, according to a study in the British Medical Journal, women who used progestogen birth control medication like Depo-Provera may be at an increased risk of developing a meningioma (perhaps as much as 5.55 times more likely to develop a meningioma tumor). Meningiomas are tumors that begin in the middle layer of tissue (arachnoid) of the membrane (meninges) surrounding the brain and spinal cord. Meningiomas can lead to complications and, in rare cases, death.
Depo-Provera Lawsuit & Settlement Cases
Depo-Provera lawsuit and settlement cases potentially being investigated include claims involving women who were diagnosed with meningioma brain tumors and/or spinal cord tumors after using Depo-Provera, Depo-SubQ Provera and/or certain generic birth control shots, including:
- Depo-Provera
- Depo-SubQ Provera
- Medroxyprogesterone acetate
It has been estimated that more than a million women each year in the United States use Depo-Provera and that about twenty percent of all women in the U.S. have used Depo-Provera, Depo-SubQ Provera or a generic form of the birth control medication at some point in their lifetime.
Plaintiffs in the Depo-Provera lawsuits may allege, among other things, that they suffered from meningioma related complications or injury after using Depo-Provera or Depo-SubQ Provera and that defendants knew or should have known that Depo-Provera may cause meningiomas but did not provide an adequate warning. The Depo-Provera lawsuit complaints may assert claims for, among other things, negligence, strict liability, breach of warranty, and violation of state statutes.
Defendants in Depo-Provera lawsuits may include manufacturers, sellers and/or distributors of brand-name Depo-Provera or Depo-SubQ Provera and/or authorized generics, such as Pfizer, Pharmacia & Upjohn Company LLC, Greenstone LLC, A-S Medication Solutions, Prasco Laboratories, or Preferred Pharmaceuticals Inc.
Depo-Provera Meningioma Lawsuit Claims
Depo-Provera meningioma lawsuit cases potentially being investigated include claims involving women who, after using Depo-Provera, Depo-SubQ Provera or a generic form of the birth control shot, were diagnosed with a meningioma brain tumor or spinal cord tumor, including:
- Meningioma
- Brain tumor
- Spinal cord tumor
- Primary brain tumor
- Central nervous system (CNS) tumor
- Convexity meningioma
- Falcine and parasagittal meningioma
- Intraventricular meningioma
- Skull base meningioma
- Sphenoid wing meningioma
- Olfactory groove meningioma
- Posterior fossa / petrous meningioma
- Suprasellar meningioma
- Other meningiomas or meningiomata
- Other Depo-Provera injury lawsuit cases
Meningiomas are the most common type of primary brain tumor, accounting for about 40 percent of all primary brain tumors. According to the National Organization for Rare Disorders (NORD), about 42,000 people in the United States are diagnosed with meningioma each year.
Meningiomas are classified as either Grade I meningiomas (slow growing, low grade tumors, representing about 80 percent of all meningioma cases), Grade II meningiomas (faster growing, mid grade tumors such as chordoid and clear cell meningiomas, accounting for about 18 percent of all meningioma cases) or Grade III meningiomas (fastest growing and malignant or cancerous tumors, including anaplastic meningiomas such as papillary meningiomas and rhabdoid meningiomas, comprising about 2 percent of all meningioma cases).
Although the majority of meningiomas are benign, intracranial meningioma tumors can grow until they are very large, putting pressure on areas surrounding the affected areas of the brain or spinal cord.
Meningioma Signs & Symptoms
Signs and symptoms of meningioma can include:
- Seizures
- Blurred vision
- Seeing double
- Headaches (worse in morning)
- Loss of balance
- Weakness in arm(s)
- Weakness in leg(s)
- Numbness
- Hearing loss
- Ringing in ears
- Memory issues
- Loss of sense of smell
- Difficulty speaking
- Slurred speech
- Confusion
- Trouble focusing
- Aphasia
- Cognitive difficulties
- Dizziness
- Personality change
- Palsy
- Pain
- Other meningioma symptoms or signs
Procedures and tests used by neurologists, oncologists, radiologists and other physicians to diagnose meningiomas can include a patient history, physical examination, neurological exam, brain scans (MRI with contrast, CT scans, X-rays, etc.) to check for “dural tail signs” or meningeal signs (i.e., thickening of the dura mater, the outer layer of the meninges), biopsy of tumor tissue, among others.
Meningioma Treatment
Treatment for meningiomas can include surgery (for example, a maximum gross total surgical resection), radiation treatment (external beam radiotherapy, brachytherapy, stereotactic radiosurgery SRS, fractionated stereotactic radiotherapy SRT, intensity-modulated radiation therapy IMRT) and chemotherapy, among others.
If not treated, meningiomas can lead to serious complications and may be life-threatening, even when benign, since they can grow and intrude on brain tissue, nerves, blood vessels and other structures.
Time Is Limited To File A Depo-Provera Lawsuit
Deadlines called statutes of limitation and statutes of repose may limit the time that women have to file a Depo-Provera lawsuit to try to recover compensation for injuries they claim to have suffered (e.g., complications relating to meningioma brain tumors or spinal cord tumors) after using Depo-Provera, Depo-SubQ Provera or medroxyprogesterone acetate.
This means that if a Depo-Provera lawsuit claim is not filed before the applicable deadline or limitations period, the injured party may be barred from ever pursuing litigation or taking legal action regarding their Depo-Provera injury claim. That is why it is important to connect with a Depo-Provera injury lawyer or attorney as soon as possible.
If you or a loved one have suffered from meningioma brain and/or spinal cord tumors after using Depo-Provera or Depo-SubQ Provera, you may be entitled to recover compensation from a Depo-Provera lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Pfizer, Pharmacia & Upjohn Company LLC, Greenstone LLC, A-S Medication Solutions, Prasco Laboratories, or Preferred Pharmaceuticals Inc.) or product (e.g., Depo-Provera or Depo-SubQ Provera) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form to request a free attorney review.